EUVIMEDEUVIMED entdecken
Open Access

Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda

Welmoed van Loon, Rafael Oliveira, Clara Bergmann, Felix Habarugira, Costanza Tacoli, Julia Jäger, Darius Savelsberg, Djibril Mbarushimana, Jules M Ndoli, Augustin Sendegeya, Claude Bayingana, Frank P Mockenhaupt

The American Journal of Tropical Medicine and Hygiene · 2023

DOI: 10.4269/ajtmh.23-0143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Welmoed van Loon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of International Health, Center for Global Health, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Malaria, Vivax, Malaria, Malaria, Falciparum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmodium vivax is the second-most common malaria pathogen globally, but is considered very rare in the predominantly Duffy-negative sub-Saharan African population. In 259 malaria patients from highland southern Rwanda, we assessed Plasmodium species and Duffy blood group status by polymerase chain reaction (PCR). Plasmodium falciparum , P. vivax , Plasmodium malariae , and Plasmodium ovale were seen in 90.7%, 8.1%, 11.6%, and 5.0%, respectively. Plasmodium vivax occurred more frequently as a monoinfection than in combination with P. falciparum . All P. vivax –infected individuals showed heterozygous Duffy positivity, whereas this was the case for only 3.1% of patients with P. falciparum monoinfection and malaria-negative control subjects ( P < 0.01). Based on PCR diagnosis, P. vivax is not rare in southern Rwanda. All episodes of P. vivax were observed in heterozygous Duffy-positive patients, whereas elsewhere in Africa, P. vivax is also reported in Duffy-negative individuals. Refined mapping of Plasmodium species is required to establish control and elimination strategies including all malaria species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, VivaxMalariaMalaria, FalciparumHumansRwandaPlasmodium vivaxPlasmodium falciparumPlasmodium malariaeDuffy Blood-Group System

Substanzen

Duffy Blood-Group System

Autor:innen und Institutionen

  • Institute of International Health, Center for Global Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Pathology Department, University Teaching Hospital of Butare, Huye, Rwanda.
  • Malaria Molecular Epidemiology Unit Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
  • Associatid Group Immune Ontogeny and Viral Infections, Leibniz Institute of Virology, Hamburg, Germany.
  • Clinical Education and Research Division, University Teaching Hospital of Butare, Huye, Rwanda.

Zitieren

APA

van Loon, W., Oliveira, R., Bergmann, C., Habarugira, F., Tacoli, C., Jäger, J., Savelsberg, D., Mbarushimana, D., Ndoli, J. M., Sendegeya, A., Bayingana, C., & Mockenhaupt, F. P. (2023). Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0143

Vancouver

van Loon W, Oliveira R, Bergmann C, Habarugira F, Tacoli C, Jäger J, et al. Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.23-0143

BibTeX
@article{vanLoon2023,
  author = {van Loon, Welmoed and Oliveira, Rafael and Bergmann, Clara and Habarugira, Felix and Tacoli, Costanza and Jäger, Julia and Savelsberg, Darius and Mbarushimana, Djibril and Ndoli, Jules M and Sendegeya, Augustin and Bayingana, Claude and Mockenhaupt, Frank P},
  title = {Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2023},
  doi = {10.4269/ajtmh.23-0143}
}
Kostenlos starten →